Related references
Note: Only part of the references are listed.Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies
Jun Hee Lee et al.
SCIENCE (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Cellular quiescence caused by the Mdm2 inhibitor nutlin-3a
Lioubov G. Korotchkina et al.
CELL CYCLE (2009)
Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence
Zoya N. Demidenko et al.
CELL CYCLE (2009)
Rapamycin decelerates cellular senescence
Zoya N. Demidenko et al.
CELL CYCLE (2009)
Regulation of Protein Synthesis by Ionizing Radiation
Steve Braunstein et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer Cells
Baoying Huang et al.
MOLECULAR CANCER RESEARCH (2009)
Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma
E. Drakos et al.
LEUKEMIA (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1)
Constantina Constantinou et al.
BIOLOGY OF THE CELL (2008)
p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling
Andrei V. Budanov et al.
CELL (2008)
Growth stimulation leads to cellular senescence when the cell cycle is blocked
Zoya N. Demidenko et al.
CELL CYCLE (2008)
The tumor suppressor p53 - Cancer and aging
Zhaohui Feng et al.
CELL CYCLE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
E. V. Broude et al.
ONCOGENE (2007)
Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations
Zhaohui Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nutlin-3 inhibits the NFκB pathway in a p53-dependent manner implications in lung cancer therapy
Anwesha Dey et al.
CELL CYCLE (2007)
Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin
Alejo Efeyan et al.
CANCER RESEARCH (2007)
Delayed ageing through damage protection by the Arf/p53 pathway
Ander Matheu et al.
NATURE (2007)
Mutations that increase the life span of C-elegans inhibit tumor growth
Julie M. Pinkston et al.
SCIENCE (2006)
Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
AJ Levine et al.
GENES & DEVELOPMENT (2006)
Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53
C Constantinou et al.
ONCOGENE (2005)
The coordinate regulation of the p53 and rnTOR pathways in cells
ZH Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
p53 is a suppressor of inflammatory response in mice
EA Komarova et al.
FASEB JOURNAL (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
p53-induced inhibition of protein synthesis is independent of apoptosis
C Constantinou et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding
WG Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Oncogenic ras and p53 cooperate to induce cellular senescence
G Ferbeyre et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells
BD Chang et al.
ONCOGENE (2000)